Norgine websites Contact us Home About Norgine Partnering Responsibility Products Careers Media Media contacts: T: +44(0) 1895 826 654 T: +44(0) 1895 826 227 contact@norgine.com Corporate news items are intended for business/trade media and for analysts/investors. Norgine B.V. celebrates 30 years of the bowel preparations used in colonoscopy to help prevent and diagnose gastrointestinal diseases, including colorectal cancer 04 October 2021 Read media release New data in the European Heart Journal show ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in elderly patients 03 October 2021 Read media release Norgine B.V. and US WorldMeds enter into exclusive licensing agreement to commercialise DFMO (eflornithine) in Europe, Commonwealth of Independent States, Australia and New Zealand 22 July 2021 Read media release Norgine B.V. enters into exclusive distribution agreement for the commercialisation of PLENVU® in China with Beijing Podconley Pharmaceutical Technology & Development Co., Ltd. 15 June 2021 Read media release Access corporate news archive Terms of Use Privacy Policy Cookie Policy Legal Entities Employee Portal Norgine B.V. Antonio Vivaldistraat 150, 1083HP Amsterdam, Nederland Tel: +31 (0)20 567 09 00 Fax: +31 (0)20 567 09 99 Handelsregister: AMSTERDAM 30127007 www.norgine.com © Norgine 2020 All product names mentioned in this website are trademarks owned by or licensed to the Norgine group of companies, unless otherwise noted.